Creation of a Prospective Acute Myocardial Infarction Data Bank

Shanghai Zhongshan Hospital1 site in 1 country3,000 target enrollmentJanuary 1, 2022

ConditionsAcute Myocardial Infarction

Overview

Phase: N/A
Intervention: Not specified
Conditions: Acute Myocardial Infarction
Sponsor: Shanghai Zhongshan Hospital
Enrollment: 3000
Locations: 1
Primary Endpoint: Database of patients with acute myocardial infarction
Status: Not Yet Recruiting
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

In order to accelerate border crossing between basic research and clinical research in acute myocardial infarction, it is necessary to easily use clinical and biological data. That is the reason why it is very important to create a clinical, biological and pathologic database of acute myocardial infarction, mainly prospective. All data are from patients treated in 5 centers in Shanghai，including Zhongshan Hospital of Fudan University, Shanghai Renji Hospital，Shanghai Tenth People's Hospital，Shanghai First People's Hospital, and Shanghai Tongji Hospital.

Registry

clinicaltrials.gov

Start Date

January 1, 2022

End Date

December 31, 2026

Last Updated

4 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Shanghai Zhongshan Hospital

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Acute myocardial infarction was diagnosed based on the Fourth Universal Definition of Acute myocardial infarction criteria. The term acute myocardial infarction should be used when there is acute myocardial injury with clinical evidence of acute myocardial ischaemia and with detection of a rise and/or fall of cTn values with at least one value above the 99th percentile URL and at least one of the following: Symptoms of myocardial ischaemia; New ischaemic ECG changes; Development of pathological Q waves; Imaging evidence of new loss of viable myocardium or new regional wallmotion abnormality in a pattern consistent with an ischaemic aetiology; Identification of a coronary thrombus by angiography or autopsy.

Exclusion Criteria

•life expectancy of less than 12 months
•malignant tumor
•pregnancy or plans of pregnancy in the one year
•any anticoagulation therapy such as heparin within 24 hours of baseline blood sampling